{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:59Z","timestamp":1787022179176,"version":"build-2736575974"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The SARS-CoV-2 Spike (S) protein is essential for viral entry and serves as the primary immunogen in most COVID-19 vaccines. While its role in adaptive immunity is well defined, its potential to contribute directly to innate immune activation remains incompletely understood. Neutrophils, in particular, are prominent effectors in COVID-19 severity, yet how they respond directly to the S protein presented in a multivalent format is unclear. Here, we investigated whether the S protein can directly activate human neutrophils\n                    <jats:italic>ex vivo<\/jats:italic>\n                    using two biologically relevant models: nanoparticles displaying multivalent stabilized prefusion trimeric S glycoprotein, and purified \u03b2-propiolactone-inactivated SARS-CoV-2 virions. Neutrophils were exposed to nanoparticles or inactivated virus, either alone or pre-coated with monoclonal or polyclonal anti-S antibodies. Nanoparticles displaying Respiratory Syncytial Virus (RSV) Fusion (F) protein and purified \u03b2-propiolactone-inactivated RSV served as comparators. Across all models and conditions tested, the S protein did not induce significant neutrophil responses. No consistent effects were observed on cell viability, surface marker expression, reactive oxygen species production, neutrophil extracellular trap formation, cytokine release, or inflammatory gene expression\u2014even in the presence of anti-S antibodies mimicking immune complexes. Results with F-nanoparticles and inactivated RSV were similarly modest. These findings indicate that the trimeric prefusion S protein, whether displayed multivalently on nanoparticles or in the context of inactivated viral particles, is insufficient to trigger robust neutrophil activation. This work provides insight into the innate immune profile of the S protein and suggests that its use in vaccine platforms is unlikely to directly provoke neutrophil-mediated inflammatory responses.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0332261","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:33:16Z","timestamp":1761759196000},"page":"e0332261","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo"],"prefix":"10.1371","volume":"20","author":[{"given":"Audray","family":"Fortin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8332-8555","authenticated-orcid":true,"given":"Sandrine","family":"Huot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Pagliuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-5018","authenticated-orcid":true,"given":"Nicolas","family":"Chomont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-1180","authenticated-orcid":true,"given":"Caroline","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-232X","authenticated-orcid":true,"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-5424","authenticated-orcid":true,"given":"Marc","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0567-0284","authenticated-orcid":true,"given":"Nathalie","family":"Grandvaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"8","key":"pone.0332261.ref001","doi-asserted-by":"crossref","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and Multiorgan Response","volume":"45","author":"S Zaim","year":"2020","journal-title":"Curr Probl Cardiol"},{"issue":"6490","key":"pone.0332261.ref002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"JB Moore","year":"2020","journal-title":"Science"},{"issue":"5","key":"pone.0332261.ref003","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"SF Pedersen","year":"2020","journal-title":"J Clin Invest"},{"issue":"10453","key":"pone.0332261.ref004","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"T Greenhalgh","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"pone.0332261.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00769-2","article-title":"Targeting the SARS-CoV-2 reservoir in long COVID","volume":"25","author":"AD Proal","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"8001","key":"pone.0332261.ref006","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41586-024-07029-4","article-title":"Prevalence of persistent SARS-CoV-2 in a large community surveillance study","volume":"626","author":"M Ghafari","year":"2024","journal-title":"Nature"},{"issue":"2","key":"pone.0332261.ref007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The Neutrophil\u2019s Role During Health and Disease","volume":"99","author":"PX Liew","year":"2019","journal-title":"Physiol Rev"},{"key":"pone.0332261.ref008","doi-asserted-by":"crossref","first-page":"864387","DOI":"10.3389\/fimmu.2022.864387","article-title":"Neutrophils in COVID-19: Not Innocent Bystanders","volume":"13","author":"E McKenna","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0332261.ref009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13054-022-04002-3","article-title":"Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity","volume":"26","author":"C Loyer","year":"2022","journal-title":"Crit Care"},{"key":"pone.0332261.ref010","doi-asserted-by":"crossref","first-page":"652470","DOI":"10.3389\/fimmu.2021.652470","article-title":"Neutrophils in COVID-19","volume":"12","author":"N Reusch","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0332261.ref011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12985-023-02116-w","article-title":"Neutrophils in COVID-19: recent insights and advances","volume":"20","author":"J Li","year":"2023","journal-title":"Virol J"},{"issue":"3","key":"pone.0332261.ref012","doi-asserted-by":"crossref","first-page":"030501","DOI":"10.11613\/BM.2021.030501","article-title":"Complete blood count alterations in COVID-19 patients: A narrative review","volume":"31","author":"M Palladino","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"pone.0332261.ref013","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","article-title":"A neutrophil activation signature predicts critical illness and mortality in COVID-19","volume":"5","author":"ML Meizlish","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"pone.0332261.ref014","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"FP Veras","year":"2020","journal-title":"J Exp Med"},{"issue":"10","key":"pone.0332261.ref015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"EA Middleton","year":"2020","journal-title":"Blood"},{"key":"pone.0332261.ref016","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.1016\/j.jtauto.2025.100280","article-title":"NETosis: A key player in autoimmunity, COVID-19, and long COVID","volume":"10","author":"DM Monsalve","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"pone.0332261.ref017","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61390","article-title":"ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities","volume":"9","author":"N Zamorano Cuervo","year":"2020","journal-title":"Elife"},{"issue":"1","key":"pone.0332261.ref018","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41392-020-00365-7","article-title":"SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic","volume":"5","author":"AM Ismail","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"6511","key":"pone.0332261.ref019","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Y Cai","year":"2020","journal-title":"Science"},{"issue":"2","key":"pone.0332261.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"AC Walls","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pone.0332261.ref021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41541-021-00369-6","article-title":"Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action","volume":"6","author":"FX Heinz","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"pone.0332261.ref022","article-title":"Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults","volume":"4","author":"BK-F Wong","year":"2024","journal-title":"Immunother Adv"},{"issue":"175","key":"pone.0332261.ref023","doi-asserted-by":"crossref","first-page":"240222","DOI":"10.1183\/16000617.0222-2024","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024","volume":"34","author":"G Zhou","year":"2025","journal-title":"Eur Respir Rev"},{"issue":"1","key":"pone.0332261.ref024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tim.2023.06.004","article-title":"SARS-CoV-2 and the spike protein in endotheliopathy","volume":"32","author":"L Perico","year":"2024","journal-title":"Trends Microbiol"},{"issue":"1","key":"pone.0332261.ref025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12035-021-02593-6","article-title":"SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia","volume":"59","author":"OA Olajide","year":"2022","journal-title":"Mol Neurobiol"},{"key":"pone.0332261.ref026","doi-asserted-by":"crossref","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"TP Buzhdygan","year":"2020","journal-title":"Neurobiol Dis"},{"key":"pone.0332261.ref027","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms","volume":"12","author":"AD Proal","year":"2021","journal-title":"Front Microbiol"},{"issue":"12","key":"pone.0332261.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2024.11.007","article-title":"Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19","volume":"32","author":"Z Rong","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"6","key":"pone.0332261.ref029","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00211-1","article-title":"Plasma-based antigen persistence in the post-acute phase of COVID-19","volume":"24","author":"MJ Peluso","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pone.0332261.ref030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients","volume":"74","author":"AF Ogata","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pone.0332261.ref031","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis","volume":"147","author":"LM Yonker","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"pone.0332261.ref032","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1007\/s12035-023-03493-7","article-title":"Recombinant SARS-CoV-2 spike protein and its receptor binding domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells","volume":"60","author":"I Tsilioni","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"7","key":"pone.0332261.ref033","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis","volume":"28","author":"IP Trougakos","year":"2022","journal-title":"Trends Mol Med"},{"issue":"596","key":"pone.0332261.ref034","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"W Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"pone.0332261.ref035","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1038\/s41598-020-74949-2","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"B Zhang","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0332261.ref036","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3201\/eid2609.201495","article-title":"Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2","volume":"26","author":"A Banerjee","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"pone.0332261.ref037","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmi.2023.03.019","article-title":"Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19","volume":"29","author":"A Fortin","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"107","key":"pone.0332261.ref038","doi-asserted-by":"crossref","DOI":"10.3791\/53723","article-title":"A high resolution method to monitor phosphorylation-dependent activation of IRF3","author":"AC Robitaille","year":"2016","journal-title":"J Vis Exp"},{"key":"pone.0332261.ref039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-0934(91)90154-R","article-title":"Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients","volume":"31","author":"A Mbiguino","year":"1991","journal-title":"J Virol Methods"},{"issue":"5","key":"pone.0332261.ref040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1159\/000360764","article-title":"Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5","volume":"6","author":"N Grandvaux","year":"2014","journal-title":"J Innate Immun"},{"issue":"3","key":"pone.0332261.ref041","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cells12030466","article-title":"Immune cells release MicroRNA-155 enriched extracellular vesicles that promote HIV-1 infection","volume":"12","author":"J Boucher","year":"2023","journal-title":"Cells"},{"issue":"8","key":"pone.0332261.ref042","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/biom13081245","article-title":"Long-Term culturing of freestyle 293-F cells affects Immunoglobulin G glycome Composition","volume":"13","author":"F Luk\u0161i\u0107","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"pone.0332261.ref043","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00003495-199958020-00009","article-title":"Palivizumab","volume":"58","author":"LJ Scott","year":"1999","journal-title":"Drugs"},{"issue":"2","key":"pone.0332261.ref044","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201205R","article-title":"DUOX2 regulates secreted factors in virus-infected respiratory epithelial cells that contribute to neutrophil attraction and activation","volume":"37","author":"DM Kasumba","year":"2023","journal-title":"FASEB J"},{"issue":"1","key":"pone.0332261.ref045","doi-asserted-by":"crossref","DOI":"10.1136\/ard.43.1.34","article-title":"Neutrophil activation by immune complexes and the role of rheumatoid factor","volume":"43","author":"R Gale","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0332261.ref046","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ard.61.1.13","article-title":"Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines","volume":"61","author":"G Fossati","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0332261.ref047","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-9255-10-12","article-title":"Activation of conventional protein kinase C (PKC) is critical in the generation of human neutrophil extracellular traps","volume":"10","author":"RD Gray","year":"2013","journal-title":"J Inflamm (Lond)"},{"key":"pone.0332261.ref048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1251\/bpo114","article-title":"Rapid and simple comparison of messenger RNA levels using real-time PCR","volume":"8","author":"A-A Dussault","year":"2006","journal-title":"Biol Proced Online"},{"issue":"4","key":"pone.0332261.ref049","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/gene.2014.8","article-title":"Evidence of impairment of normal inflammatory reaction by a high-fat diet","volume":"15","author":"C Laflamme","year":"2014","journal-title":"Genes Immun"},{"issue":"16","key":"pone.0332261.ref050","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent rsv prefusion f vaccine in older adults","volume":"388","author":"EE Walsh","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0332261.ref051","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults","volume":"388","author":"A Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"36","key":"pone.0332261.ref052","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.vaccine.2022.07.021","article-title":"Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China","volume":"40","author":"W Shenyu","year":"2022","journal-title":"Vaccine"},{"issue":"7838","key":"pone.0332261.ref053","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Z Ke","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pone.0332261.ref054","doi-asserted-by":"crossref","first-page":"10484","DOI":"10.1038\/s41598-022-13825-7","article-title":"High generation of reactive oxygen species from neutrophils in patients with severe COVID-19","volume":"12","author":"T Veenith","year":"2022","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0332261.ref055","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1096\/fj.202001085R","article-title":"IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species","volume":"34","author":"S Huot","year":"2020","journal-title":"FASEB J"},{"issue":"3","key":"pone.0332261.ref056","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"K Srivastava","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"pone.0332261.ref057","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.06.001","article-title":"Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation","volume":"53","author":"E Seydoux","year":"2020","journal-title":"Immunity"},{"issue":"11","key":"pone.0332261.ref058","article-title":"Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children","volume":"11","author":"L Garegnani","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0332261.ref059","article-title":"Nucleocapsid and spike proteins of SARS-CoV-2 drive neutrophil extracellular trap formation","volume":"21","author":"Y-J Youn","year":"2021","journal-title":"Immune Netw"},{"issue":"16","key":"pone.0332261.ref060","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.3390\/ijms241612585","article-title":"SARS-CoV-2 spike proteins and cell-cell communication induce P-selectin and markers of endothelial injury, NETosis, and inflammation in human lung microvascular endothelial cells and neutrophils: implications for the pathogenesis of COVID-19 coagulopathy","volume":"24","author":"B Bhargavan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0332261.ref061","doi-asserted-by":"crossref","first-page":"1255003","DOI":"10.3389\/fimmu.2023.1255003","article-title":"Variant-dependent oxidative and cytokine responses of human neutrophils to SARS-CoV-2 spike protein and anti-spike IgG1 antibodies","volume":"14","author":"NBF Almeida","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0332261.ref062","doi-asserted-by":"crossref","first-page":"20824","DOI":"10.1038\/s41598-022-25259-2","article-title":"SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity","volume":"12","author":"I Ait-Belkacem","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0332261.ref063","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01672-23","article-title":"SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity","volume":"15","author":"F Zhang","year":"2024","journal-title":"mBio"},{"issue":"639","key":"pone.0332261.ref064","article-title":"Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models","volume":"14","author":"H-Y Huang","year":"2022","journal-title":"Sci Transl Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:33:24Z","timestamp":1761759204000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332261"}},"subtitle":[],"editor":[{"given":"Srinivasa Reddy","family":"Bonam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332261","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.08.652856","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}